GlaxoSmithKline

GlaxoSmithKline lowers dosage to protect your heart

  • Thu, 07/05/2012 - 9:33am

GlaxoSmithKline LLC has lowered Zofran’s dosage label after preliminary results of a clinical study revealed a risk of developing an abnormal heart rhythm.

Pages